Fingerprint
Dive into the research topics of 'Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer
Nicholas W. Choong, Ann M. Mauer, Philip C. Hoffman, Charles M. Rudin, Jerome D. Winegarden, J. Lee Villano, Mark Kozloff, James L. Wade, David F. Sciortino, Livia Szeto, Everett E. Vokes
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations